Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, Jun Ishikawa, Shigeo Fuji, Hiroaki Masaie, Yuma Tada, Takahiro Karasuno, Masato Iida, Hideki Mitsui, Tsuyoshi Kamae, Norimitsu Saito, Yasuhiro Moriyama, Manabu Kawakami, Ruri Kato, Yoshiki Nakae, Toru Kida, Satoru Kosugi, Masashi Nakagawa, Yozo Uchida, Yasuhiko Azenishi, Ryoto Sakaniwa, Tetsuhisa Kitamura & Hirohiko Shibayama. (2020) Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. Leukemia & Lymphoma 61:9, pages 2113-2121.
Read now
Read now
Kento Umino, Shin-ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi & Yoshinobu Kanda. (2017) Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. Hematology 22:9, pages 521-526.
Read now
Read now
Kento Umino, Shin-Ichiro Fujiwara, Shoko Ito, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi & Yoshinobu Kanda. (2017) Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma. Leukemia & Lymphoma 58:2, pages 316-323.
Read now
Read now
Articles from other publishers (6)
Naoki Kanda, Ryota Yamaguchi, Yu Yamamoto, Masami Matsumura & Shuji Hatakeyama. (2023) Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever. Scientific Reports 13:1.
Crossref
Crossref
Fenghua Gao, Tingting Zhang, Hengqi Liu, Wei Li, Xianming Liu, Lihua Qiu, Lanfang Li, Shiyong Zhou, Zhengzi Qian, Sitong Dong, Sai Zhao, Xianhuo Wang & Huilai Zhang. (2022) Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis. Annals of Hematology 101:11, pages 2383-2392.
Crossref
Crossref
Pablo Mozas, Alfredo Rivas-Delgado, Andrea Rivero, Iván Dlouhy, Ferran Nadeu, Olga Balagué, Blanca González-Farré, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Patricia Pérez-Galán, Xavier Filella, Laura Magnano & Armando López-Guillermo. (2020) High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leukemia Research 94, pages 106371.
Crossref
Crossref
Mari Morita-Fujita, Daisuke Katoh, Yoshimitsu Shimomura & Takayuki Ishikawa. (2019) High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study. Clinical Lymphoma Myeloma and Leukemia 19:7, pages e337-e342.
Crossref
Crossref
Hajime Senjo, Minoru Kanaya, Koh Izumiyama, Koichiro Minauchi, Kenji Hirata, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, Masanobu Morioka, Daigo Hashimoto & Takanori Teshima. (2019)
Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on
18
F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma
. Cancer Medicine 8:3, pages 953-962.
Crossref
Crossref
Marie Jarosova, Eva Kriegova, Petra Schneiderova, Regina Fillerova, Vit Prochazka, Michaela Mikesova, Patrik Flodr, Karel Indrak & Tomas Papajik. (2015) A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements. Pathology & Oncology Research 22:2, pages 233-243.
Crossref
Crossref